Differential Gonadotropin-Releasing Hormone Stimulation of Rat Luteinizing Hormone Subunit Gene Transcription by Calcium Influx and Mitogen-Activated Protein Kinase-Signaling Pathways

Jennifer Weck, Patricia C. Fallest, Leslie K. Pitt and Margaret A. Shupnik

Department of Molecular Physiology and Biological Physics (J.W., M.A.S.) Department of Medicine Division of Endocrinology and The National Science Foundation Center for Biological Timing (P.C.F., L.K.P., M.A.S.) University of Virginia, Charlottesville, Virginia 22908


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
Gonadotropin secretion and gene expression are differentially regulated by hypothalamic GnRH pulses by unknown mechanisms. GnRH stimulates calcium influx through L-type voltage-gated channels and activates phospholipase C, leading to increased protein kinase C (PKC) and mitogen-activated protein kinase activity. We found differential contributions of these pathways to GnRH-stimulated rat LH subunit transcription in pituitary gonadotropes and cell lines. Endogenous transcription of the {alpha}- and LHß-subunits in rat pituitary cells was stimulated by GnRH. Independent PKC activation by phorbol myristate acid stimulated only the {alpha}-subunit gene. In contrast, an L-channel antagonist (nimodipine) inhibited only LHß stimulation by GnRH, and an L-channel agonist (BayK 8644) stimulated only basal LHß transcription. GnRH induction of a rat {alpha}-subunit promoter construct in {alpha}T3 cells was unaffected by nimodipine or elimination of external calcium, while both treatments eliminated the LHß response. Application of a mitogen-activated kinase kinase (MEK) inhibitor (PD098059) decreased basal and GnRH-stimulated {alpha}-subunit promoter activity and had no effect on LHß promoter activity. In pituitary cells from mice bearing an LHß promoter-luciferase reporter transgene, GnRH stimulation was inhibited by nimodipine but not by PD098059. Thus, GnRH induction and basal control of the {alpha}-subunit gene seem to occur through the PKC/mitogen-activated protein kinase pathway, while induction of the LHß gene is dependent on calcium influx. Differential signaling from the same receptor may be a mechanism for preferential regulation of transcription.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
The hypothalamic peptide GnRH is released into pituitary portal vessels in intermittent pulses, the frequency and amplitude of which vary physiologically (1, 2, 3, 4). Pulsatile GnRH release is necessary for reproductive function, as continuous infusion of the peptide results in infertility. GnRH acts on anterior pituitary gonadotropes to stimulate production and secretion of the gonadotropins LH and FSH. These proteins are composed of two noncovalently linked subunits, the {alpha} (common to TSH, FSH, and LH) and a ß-subunit specific to each protein. Each ß-subunit as well as the common {alpha} is encoded by different genes on separate chromosomes. LH stimulates gametogenesis and gonadal steroid production necessary for fertility. Transcriptional activation of gonadotropin subunit genes is differentially regulated by GnRH pulse frequency in vivo and in vitro (5, 6). Transcription from the rat {alpha}-subunit gene is stimulated by pulses of intermediate or short intervals, or by constant GnRH, whereas activation of the rat LHß gene occurs only with intermediate-frequency (30 min), high-amplitude pulses. Given this differential regulation, some mechanistic differences must exist.

The mechanisms by which GnRH causes such differential control within gonadotropes are unknown but may include activation of different transcription factors for each gene or preferential sensitivity to distinct second messenger pathways. These mechanisms are not mutually exclusive. Transfection experiments in cultured pituitary cells and cell lines and studies involving transgenic mice have identified several cis-acting elements responsible for expression of the human, bovine, and mouse {alpha}-subunit promoters (7, 8, 9, 10, 11). Less is known about LHß promoter regulation. However, transfection studies in primary cultures, heterologous cell lines, and transgenic mice expressing either rat or bovine LHß reporters illustrate activation of both LHß transgene and endogenous gene expression by GnRH, and this activation is attenuated in vivo by increased steroid levels or by a GnRH antagonist (12, 13, 14, 15, 16). GnRH stimulation of gonadotropes activates two primary signaling pathways, calcium and protein kinase C (PKC) (17, 18, 19, 20). Receptor activation induces a biphasic increase in internal calcium, with an initial spike dependent on internal calcium stores, and a sustained plateau that is dependent on increased Ca++ influx through L-type channels (21, 22). GnRH binding also activates G proteins (Gq{alpha} and G11{alpha}) that stimulate phospholipase C ß activity to generate inositol triphosphate and diacylgycerol. Activation of this pathway results in PKC and thus mitogen-activated protein kinase (MAPK) stimulation (23, 24, 25, 26, 27).

We sought to determine the mechanisms by which the rat {alpha} and LHß genes are regulated by GnRH. In the current study we examined rat LH subunit promoter expression in normal pituitaries, transfected cell lines, and pituitaries from mice bearing a rat LHß- promoter-luciferase transgene. By manipulating the two major pathways activated in response to GnRH, the influx of Ca++ and the activation of MAPK via PKC, we illustrate stimulation of MAPK activates the rat {alpha}-subunit gene preferentially, while Ca++ influx is more important in activating the LHß gene.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
Transcriptional Analysis of the Endogenous Genes
Transcription rates of endogenous rat {alpha} and LHß genes were measured by nuclear run-off assays in isolated rat pituitary cells treated with GnRH and various pharmacological agents (Fig. 1Go). Both genes were stimulated by GnRH ({alpha}, 5-fold, and LHß, 9-fold) but differ in their sensitivity to modulators of GnRH-signaling pathways. To determine the contribution of GnRH-stimulated increase in calcium influx through L-channels, Bay K8644, a specific L-channel agonist, and nimodipine, an L-channel antagonist, were used. Bay K only slightly increased {alpha} gene mRNA synthesis (1.5-fold) but stimulated LHß gene transcription by 7- to 9-fold, equal to the stimulation seen with GnRH. Nimodipine decreased GnRH stimulation of the {alpha} gene only partially, but had a marked effect on the LHß response, decreasing GnRH-mediated stimulation from 9- to 3-fold. The effects of PKC activation were assessed by stimulating the pathway with the phorbol ester phorbol myristate acid (PMA). PMA stimulated {alpha}-subunit mRNA synthesis 4-fold, but did not significantly increase transcription of the LHß gene. Therefore, although GnRH stimulation of pituitary gonadotropes activates both the Ca++- and PKC-regulated second messenger systems, these pathways do not affect rat {alpha}-subunit and LHß gene transcription identically. The {alpha}-subunit gene is much more susceptible to stimulation by the PKC pathway, and increases in Ca++ influx preferentially stimulate LHß gene transcription.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. Transcription Rates of Endogenous LH Subunit Genes in Isolated Rat Pituitaries

mRNA synthesis from endogenous {alpha} and LHß genes was measured in response to different treatments. Dispersed pituitary cells were treated for 30 min with GnRH (10 nM), the PKC activator PMA (100 nM), the L-type calcium channel agonist BayK8644 (BayK, 50 nM), or the L-type calcium channel antagonist nimodipine (100 nM). Nuclei were then isolated and transcription rates measured. Values are expressed in parts per million (ppm) and represent mean ± SEM for three or four samples per group. * indicates P < 0.05 and ** P < 0.01 vs. control.

 
Transfection Studies
Transfection data were supported by studies in which the homologous rat LHß promoter from -617 to +41 was stimulated by GnRH when transfected into RC4B cells (5.17 ± 3.17 arbitrary light units (ALU)/100 µg protein vs. 1.0 ± 0.26 ALU/100 µg protein for control). Nimodipine eliminated GnRH-induced promoter activity (0.96 ± 0.02 ALU/100 µg protein) as in endogenous gene transcription experiments. To investigate both subunit genes in a gonadotrope line with well characterized signaling pathways, transfections were performed in {alpha}T3 cells. Luciferase constructs containing the homologous {alpha} promoter ({alpha}LUC) or the GnRH-responsive portion of the LHß gene fused to a heterologous nonresponsive thymidine kinase (tk) minimal promoter were used (LHßtkLUC). The LHßtkLUC construct consistently responded to GnRH in both RC4B and {alpha}T3 cell lines while expression of a tkLUC control was unchanged by GnRH or any other treatment.

In {alpha}T3 cells, GnRH stimulated both {alpha}LUC and LHßtkLUC reporter activity (Fig. 2Go). Chelation of external calcium with EGTA did not alter the {alpha}LUC response to GnRH. However, the same amount of EGTA in the media decreased GnRH stimulation of LHßtkLUC to basal levels. EGTA alone had no effect on either construct. GnRH stimulation of {alpha}LUC was slightly decreased with nimodipine, the specific L-channel antagonist (Fig. 2Go). In contrast, application of nimodipine eliminated GnRH activation of LHßtkLUC, indicating that calcium influx through L-type voltage-gated channels is necessary for GnRH stimulation of the LHß promoter region.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Effect of GnRH-induced Calcium Influx on LH Subunit Reporters in {alpha}T3 Cells

{alpha}T3 cells were transfected with either {alpha}LUC or LHßtkLUC for 16 h and then treated for 6 h with EGTA (2 mM) or nimodipine (Nimo 100 nM) in the presence or absence of GnRH (10 nM). Normalized values relative to untreated controls are shown and represent the average of four to eight experiments. ** indicates P < 0.01 and *** indicates P < 0.001 as compared with paired controls.

 
The contribution of GnRH-induced protein kinase C activation to the transcriptional response was also examined. As PKC stimulation of the mouse and human {alpha}-subunit genes in primary cultures and {alpha}T3 cells has been shown to result in MAPK activation, we examined the sensitivity of the rat {alpha} and LHß gene GnRH-responsive regions to this pathway (25, 26). Transfected cells were treated with GnRH in the absence or presence of the specific MAPK kinase (MEK) inhibitor PD098059. Basal and GnRH-stimulated levels of {alpha}LUC were both decreased in the presence of this inhibitor. While GnRH stimulated the reporter with the inhibitor present, the extent of this stimulation was less than in the absence of the inhibitor. PD098059 did not significantly alter basal activity of LHßtkLUC, and GnRH treatment stimulated reporter activity (Fig. 3Go). These data illustrate that while rat {alpha} promoter expression requires activation of the MAPK pathway for basal and stimulated expression, the rat LHß gene is regulated differently by MAPK. Inhibition of the MAPK pathway had no effect on the LHßtkLUC reporter, indicating this pathway is not necessary for rat LHß activation.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Effect of MEK Inhibitor on LH Subunit Reporters in {alpha}T3 Cells

{alpha}T3 cells were transfected with either {alpha}LUC or LHßtkLUC for 16 h and then treated with the MEK inhibitor PD098059 (50 µM) in the presence or absence of GnRH. Normalized values relative to untreated controls are shown and represent the average of four to eight experiments. *** indicates P < 0.001 as compared with basal levels. a indicates P < 0.05 as compared with PD treatment.

 
Transgenic Mouse Studies
To examine the homologous rat LHß promoter in a more physiological setting, we measured luciferase activity in pituitaries from transgenic female mice containing 2 kb of the rat LHß 5'-flanking region fused to a luciferase reporter. The response of this LHß-LUC transgene to GnRH, antide (a GnRH antagonist) and gonadal steroids in vivo has been well documented (15). Isolated pituitary cells were stimulated with GnRH or treated with nimodipine or PD098059 plus GnRH (Fig. 4Go). Nimodipine eliminated GnRH stimulation of the LHß reporter, while PD did not effect GnRH induction. These results agree with transcription data from the endogenous gene (Fig. 1Go) and with transfection data (Figs. 2Go and 3Go), illustrating the relative importance of Ca++ influx in activating the LHß gene. Similar results were observed with pituitaries from both males and females, and inhibitors did not affect basal promoter activity (data not shown).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. LHß Promoter Stimulation in Transgenic Mice

Isolated pituitary cells from male transgenic mice bearing the LHß-luciferase transgene were treated for 4 h with GnRH (10 nM), PD098059 (50 µM), or nimodipine (100 nM). *, P < 0.05 vs. control for six samples per group.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
Pulsatile release of hypothalamic GnRH is necessary for pituitary LH synthesis and secretion in a variety of species (1, 2, 3, 4). Its importance in rodents is illustrated by the hypogonadal mouse, where lack of pulsatile GnRH results in loss of LH production and therefore inadequate gonadal development (28). Replacement of pulsatile GnRH in these mice restores production of LH and gonadal steroids. Messenger RNA levels and gene transcription of all three gonadotropin subunits ({alpha}, FSHß, and LHß) are differentially modulated by specific GnRH pulse frequencies in vivo and in vitro (5, 6). Our results demonstrate the rat {alpha}-subunit and LHß gene GnRH-responsive regions can also be differentially activated by Ca++ influx and the PKC/MAPK pathways. Stimulation of the rat LHß gene requires pulsatile GnRH in vitro, while the {alpha}-subunit gene can be stimulated by pulsatile or constant GnRH. GnRH pulses also increase GnRH receptor levels, thus amplifying the signal (20). One mechanism to favor LHß vs. {alpha}-subunit gene transcription, therefore, could be due to increased receptor levels caused by pulsatile GnRH. This is supported by studies in a somatomammotrope cell line stably transfected with the GnRH receptor and transiently transfected with human {alpha}, rat LHß, and rat FSHß promoter-reporter constructs. GnRH receptor density correlates with preferential gonadotrope subunit promoter activation, with high density favoring GnRH stimulation of the LHß gene (29). However, {alpha}T3 cells do not increase the level of GnRH receptor mRNA in response to GnRH (30). Additionally, stimulation of both LH subunit reporters occurred with the same GnRH application, so that any increase in receptor number would be identical in both cases. The different stimulation of the rat LH subunits by different second messengers here indicates that mechanisms other than change in receptor number are also involved. Our studies on endogenous gene transcription, expression of GnRH-responsive areas in transfected cells, and LHß promoter activity in transgenic mice indicate that differential sensitivity to second messenger pathways exists in a physiological context.

The requirement for MAPK activation for GnRH stimulation of the rat {alpha} promoter agrees with data using the mouse and human {alpha}-subunit promoters (25, 26). GnRH activation of the mouse {alpha}-subunit promoter was attenuated by overexpression of a kinase-defective MAPK or overexpression of MAPK phosphatase 2 in {alpha}T3 cells (25). The transcription factors binding the GnRH-responsive region of the mouse gene have not been described although one has been postulated to be an Ets family protein. Members of this family have been demonstrated to be phosphorylated and activated by MAPK (31, 32). The DNA-binding domains of two family members, Ets-2 and ER81, contact a GGAA sequence in the mouse GnRH response element, and cotransfection with a dominant negative Ets-2 reduces GnRH stimulation. Others demonstrated that both PKC depletion and cotransfection of dominant negative MAPK (ERK1 and ERK2) suppress basal and GnRH-stimulated human {alpha}-subunit promoter activity (26, 27). The human and mouse {alpha}-subunit genes contain an Ets domain protein-binding site in the GnRH-responsive regions, whereas the rat gene contains two, between bases -411 and -375.1 Thus, all the {alpha}-subunit genes contain potential sites for binding proteins directly activated by MAPK. Several studies illustrate the dependence of human {alpha}-subunit promoter expression on both calcium influx and PKC activation in {alpha}T3 cells (33, 34). In our experiments, GnRH-induced rat {alpha}-subunit promoter activity was only slightly affected by nimodipine or by chelation of external calcium by EGTA, indicating that external calcium influx has less influence on the rat {alpha} than the human {alpha}-subunit promoter when studied in the same cell context. As promoter sequence homology between species ranges from 71–90%, some differences in DNA sequence within the GnRH-sensitive region or other promoter areas could account for observed variations in the transcriptional responses to calcium vs. MEK-stimulated pathways.

The differences in transcriptional responses of the rat LH subunit genes are reflected in promoter sequences (12, 41). No Ets family-binding sites were identified in the rat LHß GnRH-responsive region between -617 and -245, perhaps explaining the relative lack of sensitivity to the MEK/MAPK pathway. Steroidogenic factor-1 (SF-1) sites are found in the {alpha}-subunit, GnRH receptor, and rat and bovine LHß subunit promoters and are critical for basal activity of these genes in vitro and in vivo (35, 36, 37). However, these SF-1 sites are not contained in the GnRH-responsive portion of the rat LHß reporter used in transfection studies. Others have also suggested that these SF-1 sites are not primarily responsible for GnRH stimulation of this gene (36). Our studies using transgenes, transfection constructs, and endogenous LHß gene activity show similar sensitivity to pharmacological agents and suggest that calcium influx plays a major role in GnRH stimulation of this gene. Calcium-sensitive activation is not regulated by a single transcription factor, and several types of transcription factor-binding sites and different transcription factors can contribute to stimulation by this pathway (38, 39). Cross-talk between signaling pathways has also been noted in gonadotropes and other cell types; therefore, cooperation between PKC stimulation and calcium influx may also occur, and this could result in LHß stimulation (17, 38, 39, 40).

The results of these studies in a variety of experimental systems demonstrate that the rat LH subunit genes are differentially stimulated by the two signaling pathways activated by the GnRH receptor. The relative concentrations of molecules contributing to these pathways are unknown but could vary with GnRH pulses. Even a single GnRH pulse, for example, induces internal Ca++ oscillations in gonadotropes, suggesting complicated dynamics involving multiple cellular compartments (41). The GnRH receptor can also couple to multiple G proteins, enabling preferential associations under different GnRH concentrations and regimens to occur (23, 42). Differential signaling pathways may also be activated by the same receptor, as both the {alpha}- and ß{gamma}-subunits of an individual G protein can affect second messenger pathways (43, 44, 45). These results suggest a mechanism by which separate genes can be preferentially modulated by a single ligand in a physiologically relevant manner.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 
Transcription Run-Off Assays
Dispersed pituitary cells from male CD-1 rats (200–250 g, Charles River Laboratories, Wilmington, MA) were treated for 30 min with 10-8 M GnRH, the PKC activator PMA (10-7 M), the L-type Ca++ channel agonist Bay K8644 (5 x 10-7 M) (Calbiochem, San Diego, CA), or the L-type Ca++ channel antagonist nimodipine (10-7 M) (46, 47). Nimodipine was added 15 min before GnRH treatment. Transcription rates of the endogenous {alpha} and LHß genes were analyzed in isolated nuclei incubated with [{alpha}32P]uridine triphosphate as previously described (47, 48). Values are expressed in parts per million and are the mean ± SEM for three or four independent samples per group. Statistical significance was assessed using multiple comparisons among group means by Tukey’s wholly significant difference procedure.

Vector Preparation
The rat {alpha} promoter from -411 to +77 bp relative to the transcriptional start site (see footnote 1) was generated from genomic DNA via PCR using primers specific to the rat {alpha} sequence and conserved regions of the human and mouse {alpha}-subunit genes (10, 11, 49). DNA was sequenced by the Sanger method (50) and subcloned into a luciferase reporter vector. For the rat LHß gene, two constructs were used. The homologous promoter construct, containing -617 to +41 bp relative to the transcriptional start site, was fused to the luciferase reporter and used in RC4B cells. A construct containing the GnRH-responsive region (-617 to -245 bp) of the rat LHß promoter fused to the tk minimal promoter and cloned into the luciferase reporter vector was used in {alpha}T3 cells. The LHß gene region from -245 to -100 bp was unresponsive to GnRH in RC4B or {alpha}T3 cells (data not shown), and the tk promoter was unaffected by any treatment used.

Cell Cultures and Transfections
RC4B cells express PRL and the gonadotropins, have functional GnRH receptors, and can express both the {alpha} and LHß genes (51). RC4B (8 x 106 cells) were incubated with 80 µg of the LHß promoter construct in a total volume of 0.8 ml Dulbecco’s PBS, transfected by electroporation at 320 mV and 960 µFarads (Bio-Rad, Richmond, CA), and divided into eight 60-mm wells. {alpha}T3 cells are a clonal gonadotropin line that expresses the {alpha}-subunit but not LHß or FSHß. These cells contain GnRH receptors, and the response to GnRH has been well characterized (20, 21, 22, 23, 24, 25). {alpha}T3 cells were grown in DMEM with 2 mM L-glutamine, 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells (1 x 106/60-mm well) were plated 36–48 h before CaPO4 transfection with 5 µg of the {alpha} or LHß reporter per well. Cells were transfected for 16 h, washed, and treated. For all studies, 10-7 M GnRH or 10-7 M of the des-gly agonist (GnRHa), 2 mM EGTA, 5 x 10-7 M PMA, and/or 10-7 M nimodipine were applied for 6 h, with nimodipine added 15 min before GnRH. In some experiments 50 µM PD098059 (Calbiochem, San Diego, CA), a specific MEK inhibitor, was applied 30 min before GnRH (52). Inhibition of MEK activity by PD098059 was verified in parallel studies by measuring MAPK phosphorylation with an antibody specific to the tyr-phosphorylated form (New England BioLabs, Beverly, MA). After treatments, cells were washed, collected in 250 µl lysis buffer (Promega, Madison WI), vortexed, spun for 1 min, and assayed in a Turner 20-e luminometer (Turner Designs, Mountain View, CA). Cell lysates were also used to determine protein concentrations using the colorimetric Bio-Rad protein assay system. Results are expressed as ALUs per 100 µg protein. All data were normalized and compared with untreated controls equal to 1.0. Data represent the averages of three to eight separate experiments and were analyzed using Student’s t test comparing treatment groups to respective controls.

Transgenic Mice
Mice expressing a -2.0 kb to +41 bp LHß promoter-luciferase reporter transgene were previously described (15). These animals express LHß promoter activity specifically in the pituitary, and this activity is regulated in vivo by gonadectomy, steroids, and a GnRH antagonist. Pituitaries from transgenic female mice over 5 weeks old were removed and treated as previously described (15, 48). Cells were then treated with 10-7 M GnRH, or GnRH in addition to 10-7 M nimodipine, or 50 µM PD098059. Nimodipine and PD were given 30 min before 4-h stimulation by GnRH. Pituitaries were processed and luciferase activity was assayed as described (15). Statistical significance was assessed using multiple comparisons by Tukey’s significant difference procedure.


    ACKNOWLEDGMENTS
 
We thank Drs. Nancy Cooke and Jean Rica of the University of Pennsylvania Transgenic Mouse Core Facility, who performed DNA injections to establish founder mouse lines. We also thank Drs. Derek Schreihofer, Suzanne Moenter, and Martin Straume for helpful discussions and careful reading of the manuscript.


    FOOTNOTES
 
Address requests for reprints to: Margaret A. Shupnik, Box 578 Health Science Center, University of Virginia, Charlottesville, Virginia 22908. e-mail: mas3x@virginia.edu.

This work was supported by NIH Grants R01 HD25719 (to M.A.S.) and NRSA F32MH10152 (to P.C.F.), the Center for Cellular and Molecular Research in Reproduction (P30 HD28934), and the National Science Foundation Center for Biological Timing (DIR 890162) at the University of Virginia.

1 Rat glycoprotein hormone {alpha}-subunit sequence submitted to GenBank. Accession number AF016702. Back

Received for publication October 24, 1997. Revision received November 20, 1997. Accepted for publication November 24, 1997.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 RESULTS
 DISCUSSION
 MATERIALS AND METHODS
 REFERENCES
 

  1. Belchetz PE, Plant TM, Nakai Y, Keough EJ, Knobil E 1978 Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202:631–633[Medline]
  2. Crowley Jr WF, Filicori M, Spratt D, Santoro N 1985 The physiology of gonadotropin-releasing hormone (GnRH) in men and women. Recent Prog Horm Res 41:473–526[Medline]
  3. Marshall JC, Dalkin AC, Haisenleder DJ, Paul SJ, Ortolano GA, Kelch RP 1991 Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles. Recent Prog Horm Res 47:155–187[Medline]
  4. Levine JE, Ramirez VD 1982 Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectory as estimated with push-pull cannulae. Endocrinology 111:1439–1448[Medline]
  5. Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC, Shupnik MA 1991 A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 128:509–517[Abstract]
  6. Shupnik MA 1990 Effects of gonadotropin-releasing hormone on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for luteiniz-ing hormone-ß gene stimulation. Mol Endocrinol 4:1444–1450[Abstract]
  7. Hamernik DL, Keri RA, Clay CM, Clay JN, Sherman GB, Sawyer Jr HR, Nett TM, Nilson JH 1992 Gonadotrope- and thyrotrope-specific expression of the human and bovine glycoprotein hormone {alpha}-subunit genes is regulated by distinct cis-acting elements. Mol Endocrinol 6:1745–1755[Abstract]
  8. Schoderbek WE, Kim KE, Ridgway EC, Mellon PL, Maurer RA 1992 Analysis of DNA sequences required for pituitary-specific expression of the glycoprotein hormone alpha-subunit gene. Mol Endocrinol 6:893–903[Abstract]
  9. Horn F, Windle JJ, Barnhart KM, Mellon PL 1992 Tissue-specific gene expression in the pituitary: the glycoprotein hormone alpha-subunit gene is regulated by a gonadotropin-specific protein. Mol Cell Biol 12:2143–2153[Abstract]
  10. Kay TWY, Jameson JL 1992 Identification of a gonadotropin-releasing hormone-responsive region in the glycoprotein hormone {alpha}-subunit promoter. Mol Endocrinol 6:1767–1773[Abstract]
  11. Schoderbek WE, Roberson MS, Maurer RA 1993 Two different DNA elements mediate gonadotropin releasing hormone effects on expression of the glycoprotein hormone {alpha}-subunit gene. J Biol Chem 268:3903–3910[Abstract/Free Full Text]
  12. Jameson L, Chin WW, Hollenberg AN, Chang AS, Habener JF 1984 The gene encoding the ß-subunit of rat luteinizing hormone. Analysis of gene structure and evolution of nucleotide sequence. J Biol Chem 259:15474–15480[Abstract/Free Full Text]
  13. Kim KE, Day KH, Howard P, Salton SRJ, Roberts SJL, Maurer RA 1990 DNA sequence required for expression of the LHß promoter in primary cultures of rat pituitary cells. Mol Cell Endocrinol 74:101–107[CrossRef][Medline]
  14. Clayton RN, Lalloz MR, Salton SR, Roberts JL 1991 Expression of luteinising hormone-ß subunit chloramphenicol acetyltransferase (LH-ß-CAT) fusion gene in rat pituitary cells: induction by cyclic 3'-adenosine monophosphate (cAMP). Mol Cell Endocrinol 80:193–202[CrossRef][Medline]
  15. Fallest PC, Trader GL, Darrow JM, Shupnik MA 1995 Regulation of rat luteinizing hormone beta gene expression in transgenic mice by steroids and a gonadotropin-releasing hormone antagonist. Biol Reprod 53:103–109[Abstract]
  16. Keri RA, Wolfe MW, Saunders TL, Anderson I, Kendall SK, Wagner T, Yeung J, Gorski J, Nett TM, Camper SA, Nilson JH 1994 The proximal promoter of the bovine luteinzing hormone ß-subunit gene confers gonadotrope-specific expression and regulation by gonadotropin-releasing hormone, testosterone, and 17ß-estradiol in transgenic mice. Mol Endocrinol 8:1807–1816[Abstract]
  17. Andrews WV, Maurer RA, Conn PM 1988 Stimulation of rat luteinizing hormone-ß messenger RNA levels by gonadotropin releasing hormone: apparent role for protein kinase C. J Biol Chem 263:13755–13761[Abstract/Free Full Text]
  18. Ben-Menaham D, Noar, Z 1994 Regulation of gonadotropin mRNA levels in cultured rat pituitary cells by gonadotropin-releasing hormone (GnRH): role for Ca2+ and protein kinase C. Biochemistry 33:3698–3704[Medline]
  19. Horn F, Bilezikjian LH, Perrin MH, Bosna MM, Windle JJ, Huber KS, Blount AL, Hille B, Vale W, Mellon PL 1991 Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of gonadotrope lineage. Mol Endocrinol 5:347–355[Abstract]
  20. Kaiser UB, Conn PM, Chin WW 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH-receptor expressing cell lines. Endocr Rev 18:46–70[Abstract/Free Full Text]
  21. Stojilkovic SS, Torsello A, Iida T, Rojas E, Catt KJ 1992 Calcium signaling and secretory responses in agonist-stimulated pituitary gonadotropes. J Steroid Biochem Mol Biol 41:453–467[CrossRef][Medline]
  22. Merelli F, Stojilkovic SS, Iida T, Krsmanovic LZ, Zheng L, Mellon PL, Catt KJ 1992 Gonadotropin-releasing hormone-induced calcium signaling in clonal pituitary gonadotrophs. Endocrinology 131:925–932[Abstract]
  23. Hsieh KP, Martin TF 1992 Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphospate-binding proteins Gq and G11. Mol Endocrinol 6:1673–1681[Abstract]
  24. Shah BH, Milligan G 1994 The gonadotropin-releasing hormone receptor of alphaT3–1 pituitary cells regulates cellular levels of both of the phosphoinositide C-linked proteins, Gq alpha and G11 alpha, equally. Mol Pharmacol 46:1–7[Abstract]
  25. Roberson MS, Misra-Press A, Laurance ME, Stork PJS, Maurer RA 1995 A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone {alpha}-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol 15:3531–3539[Abstract]
  26. Sundaresan S, Colin IM, Pestell RG, Jameson JL 1996 Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone: evidence for the involvement of protein kinase C. Endocrinology 137:304–311[Abstract]
  27. Kay TWH, Chedersese PJ, Jameson JL 1994 Gonadotropin-releasing hormone causes transcriptional stimulation followed by desensitization of the glycoprotein hormone {alpha} promoter in transfected {alpha}T3 gonadotrope cells. Endocrinology 134:568–573[Abstract]
  28. Saade G, London DR, Clayton RN 1989 The interaction of gonadotropin-releasing hormone and estradiol on luteinizing hormone and prolactin gene expression in female hypogonadal (hpg) mice. Endocrinology 124:1744–1753[Abstract]
  29. Kaiser UB, Sabbagh E, Katzenellenbogen RA, Conn PM, Chin WW 1995 A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone. Proc Natl Acad Sci USA 92:12280–12284[Abstract]
  30. Alarid ET, Mellon PM 1995 Down-regulation of the gonadotropin-releasing hormone receptor messenger ribonucleic acid by activation of adenylyl cyclase in {alpha}T3–1 pituitary gonadotrope cells. Endocrinology 136:1361–1366[Abstract]
  31. Coffer P, de Jonge M, Mettouchi A, Binetroy B, Ghysdeal J, Kruijer N 1993 jun B promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9:911–921
  32. O’Hagan RC, Tozer RG, Symons M, McCormick F, Hassell JA 1996 The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades. Oncogene 13:1323–1333[Medline]
  33. Holdstock HG, Aylwin SJ, Burrin JM 1996 Calcium and glycoprotein hormone {alpha}-subunit gene expression and secretion in {alpha}T3–1 gonadotropes. Mol Endocrinol 10:1308–1317[Abstract]
  34. Holdstock JG, Burrin JM 1994 Regulation of glycoprotein hormone free {alpha}-subunit secretion and intracellular {alpha}-subunit content in primary pituitary cells. Endocrinology 134:685–694[Abstract]
  35. Halvorson LM, Kaiser UB, Chin WW 1996 Stimulation of luteinizing hormone beta gene promoter by the orphan nuclear receptor steroidogenic factor-1. J Biol Chem 271:6645–6650[Abstract/Free Full Text]
  36. Ikeda Y, Luo X, Abbad R, Nilson JH, Parker KL 1995 The nuclear receptor steroidogenic factor-1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9:478–486[Abstract]
  37. Keri RA, Nilson JH 1996 A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone ß-subunit promoter in gonadotropes of transgenic mice. J Biol Chem 271:10782–10785[Abstract/Free Full Text]
  38. Barnes SJ, Conn PM 1993 Cholera toxin and dibutyryl cyclic adenosine 3', 5'-monophosphate sensitize gonadotropin-releasing hormone-stimulated inositol phosphate production to inhibition in protein kinase-C (PKC)-depleted cells: evidence for cross-talk between a cholera toxin-sensitive G-protein and PKC. Endocrinology 133:2756–2760[Abstract]
  39. Sun P, Lou L, Maurer RA 1996 Regulation of activiating transcription factor-1 and the cAMP response element binding protein by Ca2+-calmodulin dependent protein kinases type I, II, and IV. J Biol Chem 217:3066–3073[CrossRef]
  40. Garrel G, McArdle CA, Hemmings BA, Counis R 1997 Gonadotropin-releasing hormone and pituitary adenylate cyclase-activating polypeptide affect levels of cyclic adenosine 3',5'-monophosphate-dependent protein kinase A (PKA) subunit in the clonal gonadotrope {alpha}T3–1 cells. Endocrinology 138:2259–2266[Abstract/Free Full Text]
  41. Tse FW, Tse A, Hille B 1994 Cyclic Ca2+ changes in intracellular stores of gonadotropes during gonadotropin-releasing hormone-stimulated Ca2+ oscillations. Proc Natl Acad Sci USA 91:9750–9754[Abstract/Free Full Text]
  42. Hawes BE, Barnes S, Conn PM 1993 Cholera toxin and pertussis toxin provoke differential effects on luteinizing hormone release, inositol phosphate production, and gonadotropin-releasing hormone (GnRH) receptor binding in the gonadotrope: evidence for multiple guanyl nucleotide binding proteins in GnRH action. Endocrinology 132:2124–2130[Abstract]
  43. Tang W-J, Gilman A 1991 Type-specific regulation of adenylyl cyclase by G protein ß{gamma} subunits. Science 254:1500–1503[Medline]
  44. Katz A, Wu D, Simon MI 1992 Subunits beta gamma of heterotrimeric G protein activate beta 2 isoform of phospholipase C. Nature 360:686–689[CrossRef][Medline]
  45. Herlitze S, Garcia DE, Mackie K, Hille B, Scheuer T, Catterall WA 1996 Modulation of Ca++ channels by G-protein ß{gamma} subunits. Nature 380:258–262[CrossRef][Medline]
  46. Shupnik MA, Rosenzwieg BA, Showers MO 1990 Interactions of thyrotropin-releasing hormone, phorbol ester, and forskolin-sensitive regions of the rat thyrotropin-beta gene. Mol Endocrinol 4:829–836[Abstract]
  47. Shupnik MA, Weck J, Hinkle PA 1996 Thyrotropin (TSH)-releasing hormone stimulates TSH ß promoter activity by two distinct mechanisms involving calcium influx through L-type Ca2+ channels and protein kinase C. Mol Endocrinol 10:90–99[Abstract]
  48. Shupnik MA, Gharib SD, Chin WW 1989 Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Mol Endocrinol 3:474–480[Abstract]
  49. Burnside J, Buckland PR, Chin WW 1988 Isolation and characterization of the gene encoding the alpha subunit of the rat pituitary glycoprotein hormones. Gene 70:67–74[CrossRef][Medline]
  50. Sanger F, Nicklen SJ, Coulson AR 1977 DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467[Abstract]
  51. Polkowska J, Berault A, Hurbain-Kosmath I, Jolly G, Justisz M 1991 Bihormonal cells producing gonadotropes and prolactin in a rat pituitary tumor cell line. Neuroendocrinology 54:267–273[Medline]
  52. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR 1995 PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489–27494[Abstract/Free Full Text]